Training | 2023.01.05
Potential New Targets Identified in Advanced Non-Alcoholic Fatty Liver Disease
Using the latest technologies—including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells—researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD). The research was led by investigators at the Icahn School of Medicine at Mount Sinai. Utilizing these innovative methods, the investigators discovered a network of cell-to-cell communication driving scarring as liver disease advances. The findings, published online on January 4 in Science Translational Medicine, could lead to new treatments.
(PRWeb January 05, 2023)
Read the full story at https://www.prweb.com/releases/potential_new_targets_identified_in_advanced_non_alcoholic_fatty_liver_disease/prweb19098970.htm
For more information, please visit
https://www.prweb.com/releases/potential[...]iver_disease/prweb19098970.htm
